Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-11-040635
Filing Date
2011-08-09
Accepted
2011-08-09 16:32:38
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS INC 10-Q 6-30-2011 form10q.htm 10-Q 1615841
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 15186
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 16586
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 10214
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 10349
  Complete submission text file 0001140361-11-040635.txt   6625239

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rnn-20110630.xml EX-101.INS 1283826
7 XBRL SCHEMA DOCUMENT rnn-20110630.xsd EX-101.SCH 18516
8 XBRL CALCULATION LINKBASE DOCUMENT rnn-20110630_cal.xml EX-101.CAL 39118
9 XBRL DEFINITION LINKBASE DOCUMENT rnn-20110630_def.xml EX-101.DEF 39498
10 XBRL LABEL LINKBASE DOCUMENT rnn-20110630_lab.xml EX-101.LAB 146521
11 XBRL PRESENTATION LINKBASE DOCUMENT rnn-20110630_pre.xml EX-101.PRE 96496
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 111021269
SIC: 2834 Pharmaceutical Preparations